SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (A) (NYSE: A) today announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for ...
The ZORBAX RRHD 300-HILIC columns for glycopeptide analysis feature 1.8 µm particles and a 300Å pore size. These enable to resolve peptide glycoforms. The ZORBAX RRHD 300-HILIC columns are part of the ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a favorable decision in its trade secrets and breach of contract case against Advanced Materials Technology, ...
Agilent Technologies, Inc. has launched the ZORBAX Eclipse Plus line of HPLC columns, designed to deliver the resolution and separation of the challenging and critical basic compounds. "This a major ...
SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE:A), a $35 billion market cap company with a "GOOD" financial health rating according to InvestingPro, has released a new line of high performance ...
The ZORBAX Eclipse AAA high efficiency HPLC column rapidly separates amino acids following an updated and improved protocol for use with the Agilent 1100 HPLC. Total analysis from injection to ...
Agilent Technologies Inc., a global leader in analytical and clinical laboratory technologies, announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results